Whitnell & Co’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$14K Hold
48
﹤0.01% 249
2019
Q3
$12K Hold
48
﹤0.01% 249
2019
Q2
$14K Hold
48
0.01% 227
2019
Q1
$14K Hold
48
0.01% 227
2018
Q4
$13K Hold
48
0.01% 219
2018
Q3
$13K Hold
48
0.01% 222
2018
Q2
$11K Hold
48
﹤0.01% 225
2018
Q1
$11K Hold
48
﹤0.01% 242
2017
Q4
$11K Hold
48
﹤0.01% 226
2017
Q3
$9K Hold
48
﹤0.01% 216
2017
Q2
$9K Hold
48
﹤0.01% 217
2017
Q1
$8K Hold
48
﹤0.01% 230
2016
Q4
$7K Hold
48
﹤0.01% 278
2016
Q3
$6K Hold
48
﹤0.01% 281
2016
Q2
$6K Hold
48
﹤0.01% 282
2016
Q1
$7K Hold
48
﹤0.01% 256
2015
Q4
$7K Hold
48
﹤0.01% 274
2015
Q3
$7K Hold
48
﹤0.01% 271
2015
Q2
$8K Hold
48
﹤0.01% 231
2015
Q1
$7K Hold
48
﹤0.01% 232
2014
Q4
$6K Hold
48
﹤0.01% 247
2014
Q3
$6K Hold
48
﹤0.01% 242
2014
Q2
$5K Hold
48
﹤0.01% 255
2014
Q1
$5K Hold
48
﹤0.01% 253
2013
Q4
$4K Hold
48
﹤0.01% 252
2013
Q3
$4K Hold
48
﹤0.01% 247
2013
Q2
$4K Buy
+48
New +$3.59K ﹤0.01% 349

Other funds holding ELV

Whitnell & Co's ELV Position: Q4 2019 in Review

Whitnell & Co held its Elevance Health (ELV) position steady in Q4 2019 at 48 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Whitnell & Co first reported a position in ELV in Q2 2013 and has held it in 27 quarters since. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Whitnell & Co held 48 shares of Elevance Health worth $14K as of Q4 2019.
  • Whitnell & Co left its Elevance Health share count unchanged in Q4 2019.
  • Elevance Health made up ﹤0.01% of Whitnell & Co's portfolio in Q4 2019, its #249 holding.
  • Whitnell & Co first reported a position in Elevance Health in Q2 2013 and has held it in 27 quarters since.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.